日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Selective Immune Silencing by Targeted TGF-β Agonists.

靶向TGF-β激动剂选择性免疫沉默。

Sun Qinli, Ogishi Masato, Jiang Hua, Barrett Alison K, Yan Hao, Sola Elsa, Zhang Jie, Xiao Peng, Lyu Huiyun, Salehi Ahmad, Tang Qizhi, Lanz Tobias V, Davis Mark M, Negrin Robert S, Garcia K Christopher

Antibody reactivity against EBNA1 and GlialCAM differentiates multiple sclerosis patients from healthy controls.

针对 EBNA1 和 GlialCAM 的抗体反应性可以区分多发性硬化症患者和健康对照组

Sattarnezhad Neda, Kockum Ingrid, Thomas Olivia G, Liu Yicong, Ho Peggy P, Barrett Alison K, Comanescu Alexandros I, Wijeratne Tilini U, Utz Paul J, Alfredsson Lars, Steinman Lawrence, Robinson William H, Olsson Tomas, Lanz Tobias V